외과용 스테이플러 시장 : 제품별, 유형별, 용도별, 최종사용자별, 지역별, 기회, 예측(2017-2031년)

Global surgical staplers market is projected to witness a CAGR of 7.07% during the forecast period 2024-2031, growing from USD 4.95 billion in 2023 to USD 8.55 billion in 2031. The market's growth is supported by the increasing preference for surgical staples compared to sutures, rising investments by leading market players towards introducing novel devices, and augmenting requirements for surgical intervention. The rising utilization of surgical staplers can be attributed to their various advantages, including reduced operating time, enhancement of surgical precision, and faster patient recovery.

Additionally, the growing incidences of chronic diseases, including cardiovascular issues, cancer, and neurovascular conditions, among others, across the globe are also positively influencing the expansion of the global surgical staplers market. As per the estimates of the Nation Cancer Institute, approximately 2,001,140 new cases of cancer are expected to be diagnosed in 2024 in the United States. This increase is propelling the requirement for surgical staplers as they play a crucial role in open surgeries that are essential for removing cancerous tissue.

Furthermore, the increasing emphasis on developing technologically advanced solutions is boosting the availability of novel and advanced stapling devices to increase the efficiency and safety of surgical procedures. Automated and powered staplers enhance the convenience of surgeons by aiding them in achieving optimal end results without manual efforts.

Meanwhile, the changing lifestyle, expansion of the aging population, and increasing obesity are also propelling the incidences of cardiovascular conditions, augmenting the reliance on surgical methods for effective treatment and management of the condition. The World Health Organization (WHO) estimates that approximately one in six individuals across the globe will be sixty or older by 2030. Thus, increasing the chances of age-related cardiac issues, such as stiffing of heart walls that can result in heart failure, among others, thus propelling the demand for surgical procedures. According to an article published in the Indian Journal of Thoracic and Cardiovascular Surgery approximately 300,000 cardiac procedures are performed in India every year. Thus, augmenting the global surgical staplers market size due to the increased requirement for the product for effective completion of the surgical procedures.

Increasing Prevalence of Chronic Conditions to Boost the Market Demand

The rising cases of various chronic diseases and disorders across the globe are augmenting the need for surgical procedures for effective management and treatment of the conditions, which in turn is boosting the demand for surgical staplers. The increasing prevalence of different types of breast cancer is one of the major factors propelling the requirement for surgical procedures, including mastectomy. The National Breast Cancer Foundation, Inc. estimates that approximately 2,800 men and 310,720 women are going to receive a diagnosis of invasive breast cancer in the United States in 2024.

The reliance on effective tools and technologies for the successful completion of surgical procedures is rapidly increasing to simplify the procedure and ensure that the patient receives optimal care post-surgery. Surgical staplers are usually deployed in cases where wounds are hard to reach and stitch. The staples are made up of titanium, stainless steel, and plastic and allow the swift closure of topical skin wounds, reducing the surgery time.

Increasing Research and Development Activities Supports Market Expansion

The rising research and development activities by leading medical device companies and research institutions across the globe assessing the safety and effectiveness of surgical staplers in various conditions are providing lucrative growth opportunities to the market. For instance, in 2024, Teleflex Incorporated announced the publication of a new retrospective analysis of clinical data that linked Titan SGS Stapler with enhanced procedural efficiency and clinical outcomes compared to multi-fire surgical staplers in patients undergoing gastric procedures. The Titan SGS Stapler is designed and indicated for creating a sleeve gastrectomy pouch and has also received clearance from the Food and Drug Administration (FDA).

Meanwhile, different educational institutions are also conducting studies to assess the feasibility and effectiveness of stapling compared to other wound closure techniques. For instance, the University of Southern California is conducting a pilot study to determine the feasibility of different skin closure methods, namely, staples and sutures, and the rate of surgical site infections in cases of internal and open surgeries for treating orthopedic injuries. The study is estimated to conclude in December 2026.

Abdominal and Pelvic Surgery Expected to Account for Significant Market Share

The increasing requirement for abdominal surgery can be attributed to the rising incidences of conditions that affect the abdomen, including bowel disease and infections and tumors in the small intestine, stomach, colon, and spleen, among others. Furthermore, the rising cases of inflammatory bowel disease (IBD) are also propelling the requirement for abdominal surgery. According to the estimates published by the US Centers for Disease Control and Prevention in 2023, the prevalence of IBD is projected to be between 2.4 and 3.1 million in the United States. Surgery is usually adopted for treating cases of IBD when medication has been deemed ineffective in alleviating symptoms and achieving remission. Surgery is also adopted in cases where imaging or endoscopic studies show that chronic inflammation has caused severe damage to the digestive tract lining.

Additionally, the rising incidences of road accidents are a major factor propelling the requirement for pelvic surgeries due to the increasing occurrence of pelvic injuries. As per the estimates of the World Health Organization (WHO), every year, approximately 20-50 million individuals suffer from non-fatal injuries in road accidents. This propels the requirement for surgical staplers as they allow for minimal tissue interaction, quick placement, strong wound closure, and low risk of infection.

North America Holds Major Market Share

The growth of the North America surgical staplers market is supported by the strong presence of leading medical device companies, investments towards expanding the healthcare sector, and rising requirements for surgical procedures for combatting the growing threat of various diseases and disorders. Additionally, the growing efforts of medical technology companies to bolster the availability of novel products and technologies in North America are also supporting the market's growth in the region. In October 2023, Teleflex Incorporated received US FDA 510(k) approval for their Titan SGS with staple line reinforcement (SLR). Furthermore, in January 2024, the company launched the product in the U.S. market to be utilized during sleeve gastrectomy procedures.

Meanwhile, the market is expected to witness significant growth in the Asia-Pacific region over the forecast period. The rapid expansion of the market in the area can be attributed to the increasing investment in the healthcare sector in countries such as Japan, China, and India. The growing burden of chronic diseases, coupled with the rapid growth of the aging population in the region, is also propelling the requirement for surgical staplers.

Future Market Scenario (2024-2031F)

As per the global surgical staplers market analysis, the rising requirement for surgical intervention in the coming years in different regions across the globe is expected to provide lucrative growth opportunities to the market. The rising requirement for surgical procedures can be attributed to the increasing prevalence of cardiovascular conditions.

Additionally, the increasing efforts of the leading Med-Tech companies to bolster the development and availability of reusable and environmentally friendly surgical staplers while addressing the economic concerns associated with them are also expected to influence the market's expansion in the coming years positively.

The increasing occurrence of road accident injuries is also expected to augment the requirement for surgical interventions and boost the reliance on surgical staplers. As per the estimates of the WHO, by 2030, road traffic injuries are estimated to become the seventh leading cause of death worldwide.

The utilization of surgical staplers is also anticipated to increase as healthcare professionals take adequate measures to enhance patient outcomes and meet the requirement for precision in surgical procedures.

Key Players Landscape and Outlook

The market's leading players are actively working on introducing novel and advanced devices to enhance convenience for surgeons. In July 2024, Ethicon, Inc., a subsidiary of Johnson & Johnson Services, Inc., launched the ECHELON 3000 stapler, a digitally enabled device to be used in a wide range of surgical procedures, including bariatric/gastric, thoracic, and colorectal laparoscopic procedures.

Meanwhile, leading medical device companies are also engaging in mergers and acquisitions to strengthen their position in the market. In August 2022, Teleflex Incorporated purchased Standard Bariatrics, Inc. for USD 170 million upfront. The acquisition added differentiated and exciting products to Teleflex's portfolio to serve the growing sleeve gastrectomy sector.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Surgical Staplers Market Outlook, 2017-2031F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Manual Surgical Staplers
    • 4.2.1.2. Powered Surgical Staplers
  • 4.2.2. By Type
    • 4.2.2.1. Disposable Surgical Staplers
    • 4.2.2.2. Reusable Surgical Staplers
  • 4.2.3. By Application
    • 4.2.3.1. General Surgery
    • 4.2.3.2. Cardiac and Thoracic Surgery
    • 4.2.3.3. Abdominal and Pelvic Surgery
    • 4.2.3.4. Orthopedic Surgery
    • 4.2.3.5. Others
  • 4.2.4. By End-user
    • 4.2.4.1. Hospitals and Clinics
    • 4.2.4.2. Ambulatory Surgical Centers
  • 4.2.5. By Region
    • 4.2.5.1. North America
    • 4.2.5.2. Europe
    • 4.2.5.3. Asia-Pacific
    • 4.2.5.4. South America
    • 4.2.5.5. Middle East and Africa
  • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
• 4.3. Market Map Analysis, 2023
  • 4.3.1. By Product
  • 4.3.2. By Type
  • 4.3.3. By Application
  • 4.3.4. By End-user
  • 4.3.5. By Region

5. North America Surgical Staplers Market Outlook, 2017-2031F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
  • 5.1.2. By Volume
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product
    • 5.2.1.1. Manual Surgical Staplers
    • 5.2.1.2. Powered Surgical Staplers
  • 5.2.2. By Type
    • 5.2.2.1. Disposable Surgical Staplers
    • 5.2.2.2. Reusable Surgical Staplers
  • 5.2.3. By Application
    • 5.2.3.1. General Surgery
    • 5.2.3.2. Cardiac and Thoracic Surgery
    • 5.2.3.3. Abdominal and Pelvic Surgery
    • 5.2.3.4. Orthopedic Surgery
    • 5.2.3.5. Others
  • 5.2.4. By End-user
    • 5.2.4.1. Hospitals and Clinics
    • 5.2.4.2. Ambulatory Surgical Centers
  • 5.2.5. By Country Share
    • 5.2.5.1. United States
    • 5.2.5.2. Canada
    • 5.2.5.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Surgical Staplers Market Outlook, 2017-2031F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
      • 5.3.1.1.2. By Volume
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Product
        • 5.3.1.2.1.1. Manual Surgical Staplers
        • 5.3.1.2.1.2. Powered Surgical Staplers
      • 5.3.1.2.2. By Type
        • 5.3.1.2.2.1. Disposable Surgical Staplers
        • 5.3.1.2.2.2. Reusable Surgical Staplers
      • 5.3.1.2.3. By Application
        • 5.3.1.2.3.1. General Surgery
        • 5.3.1.2.3.2. Cardiac and Thoracic Surgery
        • 5.3.1.2.3.3. Abdominal and Pelvic Surgery
        • 5.3.1.2.3.4. Orthopedic Surgery
        • 5.3.1.2.3.5. Others
      • 5.3.1.2.4. By End-user
        • 5.3.1.2.4.1. Hospitals and Clinics
        • 5.3.1.2.4.2. Ambulatory Surgical Centers
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Surgical Staplers Market Outlook, 2017-2031F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Poland

7. Asia-Pacific Surgical Staplers Market Outlook, 2017-2031F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America Surgical Staplers Market Outlook, 2017-2031F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa Surgical Staplers Market Outlook, 2017-2031F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa
• 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

• 16.1. Market Drivers
• 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

• 18.1. Clinical Trials
• 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

• 21.1. Competition Matrix of Top 5 Market Leaders
• 21.2. SWOT Analysis for Top 5 Players
• 21.3. Key Players Landscape for Top 10 Market Players
  • 21.3.1. Intuitive Surgical Operations, Inc.
    • 21.3.1.1. Company Details
    • 21.3.1.2. Key Management Personnel
    • 21.3.1.3. Products and Services
    • 21.3.1.4. Financials (As Reported)
    • 21.3.1.5. Key Market Focus and Geographical Presence
    • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 21.3.2. CONMED Corporation
  • 21.3.3. B. Braun SE
  • 21.3.4. Smith & Nephew plc
  • 21.3.5. Medtronic plc
  • 21.3.6. Becton, Dickinson, and Company
  • 21.3.7. Johnson & Johnson Services, Inc.
  • 21.3.8. Frankenman International Ltd
  • 21.3.9. Meril Life Sciences Pvt. Ltd.
  • 21.3.10. BioPro, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer